IGY Life Sciences achieves 94.8% purity of IgY, opening the way for large-scale health applications for Nutraceuticals

2022-12-14T02:27:12+00:00September 7th, 2022|

Press Release  |  July 25, 2022 Thunder Bay, Ontario, Canada - July 25, 2022 – IGY Life Sciences and Immune Technologies Inc. (the "Company" or "IGY Life Sciences") is pleased to announce it has reached 94.8% purity of Muno-IgYTM, the Company’s branded nutraceutical IgY ingredient for targeting immune and gut health through supplementation of [...]

IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment

2022-12-14T02:27:58+00:00June 8th, 2020|

Businesswire  |  June 8, 2020 THUNDER BAY, Ontario--(BUSINESS WIRE)--IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, an anti-CoV-2 therapeutic antibody with a focus on a nasal spray application. This novel approach of an IgY antibody in a [...]